MedPeer

MedPeer Rule of 40

Delisted

The Rule of 40 of MedPeer (6095.T) as of Nov 16, 2026 is 11.44 %. In the previous year, Rule of 40 was 79.74 % — a change of -85.65% (lower).

Rule of 40

11.44 %

YoY

-85.65%

Last updated:

Rule of 40 of MedPeer is 2024 11.44 % . Rule of 40 of MedPeer was 2023 79.74 % . It decreases by -85.65% lower compared to the previous year.

The MedPeer Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2017
65.40 JPY
Jan 1, 2018
57.79 JPY
Jan 1, 2019
56.82 JPY
Jan 1, 2020
95.19 JPY
Jan 1, 2021
63.99 JPY
Jan 1, 2022
26.26 JPY
Jan 1, 2023
79.74 JPY
Jan 1, 2024
11.44 JPY
The MedPeer Rule of 40 history
YEARRule of 40YoY
11.44 %-85.65%
79.74 %+203.67%
26.26 %-58.96%
63.99 %-32.78%
95.19 %+67.53%
56.82 %-1.67%
57.79 %-11.64%
65.40 %-14,959.06%
-0.44 %-102.03%
21.64 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

MedPeer Stock analysis

What does MedPeer do? MedPeer Inc is a US-American company that was founded in Boston, Massachusetts in 2004. The company develops and operates social networks and platforms for doctors and medical students. The business model of MedPeer is focused on bringing doctors and medical students together on a platform where they can exchange medical information, ask and answer questions, and engage in discussions on current medical topics. MedPeer is primarily a platform that provides information and support to medical professionals and facilitates the exchange of valuable information. MedPeer also offers various specialized sections that provide specific information and support to doctors and medical students. These sections include, among others, gastroenterology, cardiology, oncology, neurology, dermatology, and mental health. In the field of gastroenterology, MedPeer provides information on the diagnosis and treatment of gastrointestinal diseases. In the field of cardiology, MedPeer provides information on the diagnosis and treatment of cardiovascular diseases. In the field of oncology, MedPeer provides information on cancer treatment. In the field of neurology, MedPeer provides information on the treatment of neurological diseases such as Alzheimer's, Parkinson's, and multiple sclerosis. In the field of dermatology, MedPeer provides information on the diagnosis and treatment of skin diseases. In the field of mental health, MedPeer provides information on the diagnosis and treatment of mental illnesses such as depression and anxiety. MedPeer also offers products that are designed to assist doctors and medical students in their work and studies. An example of this is the MedPeer Academy course, which prepares medical students for their clinical rotations and prepares them for the exam they must take at the end of their rotation period. Other products offered by MedPeer include digital medical libraries that provide access to thousands of medical articles, journals, and textbooks. Additionally, MedPeer offers various software tools designed to assist doctors in the diagnosis and treatment of patients. Over the years, MedPeer has received several awards and recognitions, including first place in the "Medical Services and Equipment" category at the Global Mobile Awards 2014. Furthermore, the company has received a significant amount of venture capital investments in recent years. The company has also recently entered into a partnership with Allm, a Japanese provider of mobile and web applications for the healthcare sector. The partnership aims to allow MedPeer to enter the Japanese market and expand its services and products to a larger audience. Overall, MedPeer has made significant progress in recent years and has become a key player in the medical information and communication industry. The company has demonstrated its ability to provide high-quality products and services that can assist doctors and medical students in their work and studies. MedPeer is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MedPeer stock

Rule of 40 of MedPeer is 11.44 % in 2024.

On Eulerpool you can find the complete historical development of Rule of 40 MedPeer since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — MedPeer

All Key Metrics — MedPeer